Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2008-10-16
pubmed:abstractText
The cardiac ryanodine receptor (RyR) controls Ca2+ release from the sarcoplasmic reticulum (SR) during excitation-contraction coupling. Three phosphorylation sites have been identified: Serine-(S)2808, S2814 and recently S2030. We measured phosphorylation with at least two different antibodies per site and demonstrate that for S2808 results were highly antibody-dependent and two out of three S2808 antibodies did not accurately report phosphorylation level. The RyR was substantially phosphorylated in quiescent rat cardiomyocytes at S2808 and less so at S2814, but appeared to be unphosphorylated at S2030. Basal phosphorylation at S2808/S2814 was maintained by a Ca2+ dependent kinase other than Ca2+/Calmodulin-dependent kinase (CaMKII). During stimulation with Isoproterenol S2808 was phosphorylated by protein kinase A (PKA) and S2814 was phosphorylated by CaMKII. Phosphatase 1 appears to be the main phosphatase dephosphorylating S2808/S2814, but phosphatase 2a may also dephosphorylate S2814. RyR phosphorylation is complex, but important in understanding RyR functional modulation.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/18755143-10830164, http://linkedlifedata.com/resource/pubmed/commentcorrection/18755143-12401811, http://linkedlifedata.com/resource/pubmed/commentcorrection/18755143-12837242, http://linkedlifedata.com/resource/pubmed/commentcorrection/18755143-14514795, http://linkedlifedata.com/resource/pubmed/commentcorrection/18755143-14556649, http://linkedlifedata.com/resource/pubmed/commentcorrection/18755143-14715536, http://linkedlifedata.com/resource/pubmed/commentcorrection/18755143-15184066, http://linkedlifedata.com/resource/pubmed/commentcorrection/18755143-15276012, http://linkedlifedata.com/resource/pubmed/commentcorrection/18755143-15790957, http://linkedlifedata.com/resource/pubmed/commentcorrection/18755143-16093511, http://linkedlifedata.com/resource/pubmed/commentcorrection/18755143-16269653, http://linkedlifedata.com/resource/pubmed/commentcorrection/18755143-1645727, http://linkedlifedata.com/resource/pubmed/commentcorrection/18755143-16483256, http://linkedlifedata.com/resource/pubmed/commentcorrection/18755143-16709901, http://linkedlifedata.com/resource/pubmed/commentcorrection/18755143-17239900, http://linkedlifedata.com/resource/pubmed/commentcorrection/18755143-1848697, http://linkedlifedata.com/resource/pubmed/commentcorrection/18755143-8046643, http://linkedlifedata.com/resource/pubmed/commentcorrection/18755143-8380171
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
1090-2104
pubmed:author
pubmed:issnType
Electronic
pubmed:day
7
pubmed:volume
376
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
80-5
pubmed:dateRevised
2010-12-3
pubmed:meshHeading
pubmed:year
2008
pubmed:articleTitle
Ryanodine receptor phosphorylation at Serine 2030, 2808 and 2814 in rat cardiomyocytes.
pubmed:affiliation
Department of Physiology, Loyola University Chicago, Maywood, IL 60153, USA; Department of Clinical Pharmacology, Vanderbilt University, Nashville, TN 37232, USA.
pubmed:publicationType
Journal Article, Research Support, N.I.H., Extramural